Posts
July 14 2021
Xenetic Biosciences, Inc. announced the closing of their Private Placement offering in the amount of $12,500,000. EG&S acted as counsel to the Placement Agent.
July 13 2021
Client Alert: NY HERO Act Model Protocols and Prevention Plans Now Available
As detailed in our previous Client Alert, the New York Health and Essential Rights Act (NY HERO Act) mandates that all private sector employers adopt workplace health and safety protections in an effort to protect employees during a future airborne infectious disease outbreak. Specifically, the NY HERO Act requires private sector employers in New York to adopt a health and safety plan to protect employees from exposure to airborne infectious diseases (a “Prevention Plan”).
Click here to read the alert.
July 12 2021
Good Works II Acquisition Corp. announced the pricing of its initial public offering in the amount of $20,000,000. EGS acted as counsel to I-Bankers.
July 12 2021
Agrico Acquisition Corp. announced the closing of its initial public offering in the amount of $143,750,000. EGS acted as counsel to the underwriter.
July 11 2021
Panbela Therapeutics, Inc. announced the closing of their Underwritten offering in the amount of $10,000,000. EG&S acted as counsel to the Underwriter.
July 10 2021
electroCore, Inc. announced the closing of their Underwritten offering in the amount of $19,000,000. EG&S acted as counsel to the Underwriter.
July 09 2021
Vista Gold Corp. announced the closing of their Underwritten offering in the amount of $13,500,000. EG&S acted as counsel to the Underwriter.
July 09 2021
Alussa Energy Acquisition Corp. and FREYR AS, a Norway-based developer of clean, next-generation battery cell production capacity announced the completion of their previously announced business combination. The combined company now operates as FREYR Battery. EGS served as securities counsel to Alussa Energy Acquisition Corp.